Role of TGF-β1, its receptor TGFβRII, and Smad proteins in the progression of colorectal cancer

International Journal of Colorectal Disease

Volumn 25, Issue 5, 2010, Pages 591-599

  Gulubova, Maya ^a   Manolova, Irena ^a   Ananiev, Julian ^a   Julianov, Alexander ^a   Yovchev, Yovcho ^a   Peeva, Katya ^a  

^a TRAKIA UNIVERSITY   (Bulgaria)

Author keywords

Colorectal cancer; Dendritic cells; Macrophages; Smad proteins; TGF TGF RII

Indexed keywords

CD68 ANTIGEN; CD83 ANTIGEN; HLA DR ANTIGEN; SMAD4 PROTEIN; SMAD7 PROTEIN; T6 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; PROTEIN SERINE THREONINE KINASE; SMAD4 PROTEIN, HUMAN; SMAD7 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR; TUMOR PROTEIN;

ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; AUTOCRINE EFFECT; CANCER GROWTH; CANCER STAGING; CELL INFILTRATION; CELL MEMBRANE; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR IMMUNITY; CELL COUNT; COLORECTAL TUMOR; DISEASE COURSE; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PATHOLOGY; PROTEIN TRANSPORT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGEN-PRESENTING CELLS; CELL COUNT; CELL MEMBRANE; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SMAD4 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77953288010     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-010-0906-9     Document Type: Article

References (35)

1. Baker K, Chong G, Foulkes WD, Jass JR (2006) Transforming growth factor-beta pathway disruption and infiltration of colorectal cancers by intraepithelial lymphocytes. Histopathology 49:371-380
2. Korchynskyi O, Landstrom M, Stoika R, Funa K, Heldin C-H, ten Dijke P, Souchelnytskyi S (1999) Expression of Smad proteins in human colorectal cancer. Int J Cancer 82:197-202
3. Elliot RL, Blobe GC (2005) Role of transforming growth factor beta in human cancer. J Clin Oncol 23:2078-2093
4. Bacman D, Merkel S, Croner R, Papadopoulos T, Brueckl W, Dimmler A (2007) TGF-beta receptor downregulation in tumor-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. BMC Cancer 7:156-166
5. Xu Y, Pashe B (2007) TGF-β signaling alterations and susceptibility to colorectal cancer. Hum Mol Genet 16 (SPEC1):R14-R20. doi:10.1093/hmg/dd1486
6. Heldin C-H, Miyazono K, ten Duke P (1997) TGF- β signaling from cell membrane to nucleus via Smad proteins. Nature 390:465-471
7. Derynck R, Feng X-H (1997) TGF- β receptor signaling. Biochim Biophys Acta 1333:F105-F150
8. Engle SJ, Hoying JB, Boivin GP, Ormsby I, Gartside PS, Doetschman T (1999) Transforming growth factor β1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res 59:3379-3386
9. Friedman E, Gold LI, Klimstra D, Zeng ZS, Winawer S, Cohen A (1995) High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer. Cancer Epidemiol Biomarkers Prev 4:549-554
10. Robson H, Anderson E, James RD, Schofield PF (1996) Transforming growth factor beta 1 expression in human colorectal tumors: an independent prognostic marker in a subgroup of poor prognosis patients. Br J Cancer 74:753-758
11. Shibahara T, Si-Tahar M, Shaw SK, Madara JL (2000) Adhesion molecules expressed on homing lymphocytes in model intestinal epithelia. Gastroenterology 118:289-298
12. Reinacher-Schick A, Baldus SE, Romdhana B, Landsberg S, Zapatka M, Monig SP, Holscher AH, Dienes HP, Schmiegel W, Schwarte-Waldhoff I (2004) Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas. J Pathol 202:412-420
13. Bates RC, Mercurio AM (2005) The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther 4:365-370
14. Talmadge JE, Donkor M, Scholar E (2007) Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Metast Rev 26:373-400
15. NakayamaY NN, Minagawa N, Inoue Y, Katsuki T, Onitsuka K, Sako T, Hirata K, Nagata N, Itoh H (2002) Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer. Anticancer Res 22:4291-4296
16. Shurin MR, Shurin GV, Lokshin A, Yurkovetsky Z, Gutkin DW, Chatta G, Zhong H, Han B, Ferris RL (2006) Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies? Cancer Metastasis Rev 25:333-356
17. Miygawa S, Soeda J, Takagi S, Miwa S, Ichikawa E, Noike T (2004) Prognostic significance of mature dendritic cells and factors associated with their accumulation in metastatic liver tumors from colorectal cancer. Hum Pathol 35:1392-1396
18. Gulubova M, Manolova I, Cirovski G, Sivrev D (2008) Recruitment of dendritic cells in human liver with metastases. Clin Exp Metast 25:777-785
19. UICC. TNM Classification of Malignant Tumours 6th ed (2002) In: Sobin LH, Wittekind Ch (eds) Wiley-Liss, New York
20. Kioshima T, Kobayashi I, Matsuo K, Ishibashi Y, Miyoshi A, Akashi Y, Sakai H (1998) Immunohistochemical localization of laminin, collagen type IV and heparan sulfate proteoglycan in human colorectal adenocarcinoma: correlation with local invasive pattern and lymph node metastasis. Acta Histochem Cytochem 31:39-47
21. Gulubova M, Vlaykova T (2006) Immunohistochemical assessment of fibronectin and tenascin and their integrin receptors alpha5beta1 and alpha9beta1 in gastric and colorectal cancers with lymph node and liver metastases. Acta Histochem 108:25-35
22. Guzinska-Ustymowicz K, Kemona A (2005) Transforming growth factor beta can be a parameter of aggressiveness of pT1 colorectal cancer. World J Gastroenterol 11:1193-1195
23. Von Rahden BHA, Stein HJ, Feith M, Puhringer F, Theisen J, Siewert R, Sarbia M (2006) Overexpression of TGF-β1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis. Mol Carcinog 45:786-794
24. Lu Y, Wu L-Q, Li C-S, Wang S-G, Han B (2008) Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis. Hepatobiliary Pancreat Dis Int 7:174-178
25. Park YN, Chae KJ, Oh B-K, Choi J, Choi KS, Park C (2004) Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-β. Hepato-Gastroenterol 51:396-400
26. Picon A, Gold LI, Wang J, Cohen A, Friedman E (1998) A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor β1. Cancer Epidemiol Biomark Prev 7:497-504
27. Chang H-L, Gillett N, Figari I, Lopez A, Palladino M, Derynck R (1993) Increased transforming growth factor β expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells. Cancer Res 53:4391-4398
28. Shim KS, Kim KH, Han WS, Park EB (1999) Elevated serum levels of transforming growth factor- β1 in patients with colorectal carcinoma. Cancer 85:554-561
29. Gold L, Saxena B, Mittalk K, Marmor M, Goswami S, Nactigal L, Kork M, Demopoulos R (1994) Increased expression of transforming growth factor β isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Cancer Res 54:2347-2358
30. Gorsch S, Memoli V, Stukel T, Gold L, Arrick B (1992) Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer. Cancer Res 52:6949-6952
31. Bellone G, Carbone A, Tibaudi D, Mauri F, Ferrero I, Smirne C, Suman F, Rivetti C, Migliaretti G, Camandona M, Palestro G, Emanuelli G, Rodeck U (2001) Differential expression of transforming growth factors- β1, -β2 and -β3 in human colon carcinoma. Eur J Cancer 37:224-233
32. Alazzouzi H, Alhopuro P, Salovaara R, Sammalkorpi H, Jarvinen H, Mecklin J-P, Hemminki A, Schwartz S, Aaltonen L, Arango D (2005) Smad4 as a prognostic marker in colorectal cancer. Clin Cancer Res 11:2606-2611
33. Isaksson-Mettavainio M, Palmqvist R, Forssell J, Stenling R, Oberg A (2006) Smad4/DPC4 expression and prognosis in human colorectal cancer. Anticancer 26:507-510
34. Javelaud D, Delmas V, Moller M, Sextius P, Andre J, Menashi S, Larue L, Mauviel A (2005) Stable verexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo. Oncogene 24:7624-7629
35. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B et al (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338